Our work helps partners determine whether an existing medicine may warrant deeper scientific, commercial, and clinical evaluation for a new therapeutic use.
-
Identifying new therapeutic uses for approved pharmaceutical assets.
-
Evaluating whether an existing drug may qualify for additional indications.
-
Structured scientific and commercial evaluation of specific compounds.
-
Designing evidence pathways to support diligence and validation.
-
Supporting investor and pharma partners in evaluating new-use opportunities.
-
Developing roadmaps for prospective validation for repurposing hypotheses.
-
Evaluating licensing, co-development, and asset transaction structures.